Ticker News
$DH News
Stored TradersLink news articles and press-release context for this ticker. Discord alerts link into these article pages when full article text is available.
Published Articles
Latest saved alerts
Definitive Healthcare names Clay Ritchey as CEO, effective Sept. 8, 2026
Definitive Healthcare (NASDAQ: DH) appointed Clay Ritchey as CEO effective Sept. 8, 2026, replacing Kevin Coop who departed Aug. 31, 2026. Ritchey — a 25+ year healthcare data executive who most recently led Verato and previously ran Evariant — said he'll push to accelerate a return to growth and roll out an AI-powered platform that pairs the company's proprietary datasets with conversational AI and workflows.
Definitive Healthcare launches early-adopter program for AI healthcare intelligence platform
Definitive Healthcare (DH) announced an early-adopter program for a new AI-powered healthcare intelligence platform, giving select health-system and life-sciences customers early access starting August 2026 ahead of planned general availability in late 2026. The platform combines the company's proprietary provider, claims, affiliation and consumer datasets with conversational AI to surface market-sizing, sales-territory, prospect-prioritization and network-management insights.
Definitive Healthcare (DH) grants 1.06M RSUs to new SVP Head of AI & Data
Definitive Healthcare (NASDAQ: DH) granted 1,063,830 inducement restricted stock units to new SVP & Head of AI & Data - Product Srinivas Attipalli, effective July 24, 2026, under Nasdaq Listing Rule 5635(c)(4). The RSUs vest 25% on June 1, 2027 with the remainder vesting in quarterly 6.25% installments thereafter, signaling a material equity incentive tied to retention and the company’s AI/data product priorities and creating potential share overhang if fully issued.